The Influence of Disulfiram or Ethanol on 1,2-Dichloroethane Carcinogenicity, Metabolism, and DNA Binding.
Authors
Cheever KL; Cholakis JM; El-hawari AM; Kovatch RM; Weisbruger EK
Source
NIOSH 1988:51-115
Link
NIOSHTIC No.
00180852
Abstract
The interaction of 1,2-dichloroethane (107062) (EDC) with disulfiram (97778) (DS) or ethanol (64175) was investigated in rats. Sprague- Dawley-rats were exposed for 24 months to 50 parts per million (ppm) concentrations of EDC in an inhalation study while at the same time being exposed to 0.05 percent DS in the diet and/or 5 percent ethanol in the drinking water. A high incidence of intrahepatic bile duct cholangiomas were reported in both sexes receiving EDC and DS, 18 percent incidence among males and 34 percent among females. Male rats also registered 12 percent incidence of hepatocellular adenomas, 22 percent incidence for interstitial cell tumors in the testes, 20 percent subcutis fibroma, and 25 percent mammary adenocarcinomas in females. The expected rates for these disorders would have been 0, 4, 4, and 8 percent, respectively. A slight increase in neoplastic nodules occurred in males receiving EDC and ethanol, 8 percent versus 0 percent expected. The DNA binding by EDC was not altered by DS treatment, and the metabolism of EDC was qualitatively the same as in corresponding controls. However, the combined treatment of EDC and DS did reduce the rate of elimination of EDC, and sustained the blood concentration levels of unchanged EDC, which may be related to the increased carcinogenic effect of the combination.
Proceedings of the Fourth NCI/EPA/NIOSH Collaborative Workshop: Progress on Joint Environmental and Occupational Cancer Studies, April 22-23, 1986, Rockville, Maryland, NIH Publication No. 88-2960, NIOSH Contract No. 200-82-2508
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.